Aurobindo Pharma

Aurobindo Pharma's net profit rises 4.6% at Rs 639.5 crore in Q2, revenues grow nearly 18%

Formulation revenues for the quarter posted a growth of 21.8% YoY to Rs 4,793.8 crore and accounted for 85.6% of total revenues.

Indian firms remain heavily taxed, how South Asia can contribute a third of global growth; all this and more on Moneycontrol Pro

The corporate tax cut was hailed as a big game-changer for Indian companies.

AstraZeneca moves US court against Aurobindo Pharma on generic version of patented drug Daliresp

Daliresp is a prescription medicine used in adults with severe Chronic Obstructive Pulmonary Disease

Novartis sells parts of Sandoz US to Aurobindo Pharma for $900 mn; Swiss drugmaker to focus on higher growth areas

The 131-year-old Sandoz unit was hurt by price pressure in the United States, prompting Novartis Chief Executive Officer Vas Narasimhan to sell the Sandoz unit.

Aurobindo Pharma gets US FDA's notice on 7 violations with drug making at Hyderabad unit

US FDA’s form 483 to Aurobindo Pharma Hyderabad unit has seven observations relating to violation of good manufacturing practices

Rayalaseema's royal war: Will Chandrababu Naidu wipe out YSR's legacy by ruining Jagan Reddy?

An uneven but pitched, dirty war is being fought between Andhra Pradesh Chief Minister Chandrababu Naidu and Leader of Opposition YS Jaganmohan Reddy and the stakes are sky high.

Aurobindo Pharma receives nod from USFDA for manufacturing cholesterol tablets

Aurobindo Pharma has received approval from the USFDA to manufacture and market Fenofibrate tablets, used for the treatment of high level of cholesterol.

Awaiting Greece crisis outcome, Sensex ends 75 points lower; oil PSUs buck trend

Market breadth, howeve, ended higher with 1,519 stocks advancing against 1,251 declines on BSE.

India scraps import duties on AIDS drugs to battle shortage in Naco efforts

Government officials have previously said about a lack of participation by local drugmakers in the tenders floated by the Naco to procure drugs.

CCEA clears Glenmark, Aurobindo foreign funding proposals worth Rs 4,187 cr

The decision was taken by the Cabinet Committee on Economic Affairs, chaired by Prime Minister Narendra Modi.